http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A108926310
Anindya Mukherjee (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India) ; Sujay Rainchwar (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India) ; Aakanksha Singh (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India) ; Rohan Halder (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India) ; Pritish Chandra Patra (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India) ; Rayaz Ahmed (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India) ; Dinesh Bhurani (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India) ; Narendra Agrawal (Department of Hemato-Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India)
2023
English
KCI등재,SCOPUS,ESCI
학술저널
240-242(3쪽)
0
상세조회0
다운로드
Recent advances in cellular immunotherapy for lymphoid malignancies
Lenalidomide as a treatment for patients with AL amyloidosis and cardiac involvement
Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing
Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma